The environment pharmaceutical companies face is changing dramatically.
People pay more and more attention to health and the innovation of medical technology. At the same time, with the society becoming more and more childless and aging, people have more expectations of hospitals that everyone, old or young, can get access to at ease.
Developed countries are trying to control rising costs of health care and drugs while also trying to reform health care for the future. Developing countries, led by Asia, also have more pursuit of high-quality pharmaceuticals.
Our company's most important aim is to constantly innovate and make high-quality medicine on the basis of accurate and reliable knowledge and experience.
In order to make a contribution to the health and betterment of all mankind, our company's researchers always keep up with the development of the times, never forget the original aspiration and constantly challenge new topics.
With this in mind, we are actively investing in the fields of research and development, production facilities and personnel training on the basis of our medium-term business plan. Under the guidance of ethics and morality, we continue to make efforts in the development and production of high-quality pharmaceuticals, and strive to provide users and patients with safe and effective high-quality pharmaceuticals.
The pursuit of generic drug manufacturers are:
Promote generic drugs to the world with stable supply, reliable quality and accurate information.
Japan is the first developed country to experience an ageing society, but the spread of generics has not caught up. In the future, the country will encourage more and more people to use generic drugs, accelerate the commercialization of generic drugs, and at the same time, the price war will be increasingly fierce.
In addition to developed countries, developing countries are facing the problem of drug costs caused by the aging society. Therefore, generic drugs also have great development potential overseas.
Our company Kokando always insist on high quality management and strict manufacturing management, in order to provide customers and patients with high quality drugs at affordable prices.
Based on the basic requirements of the quality management manual, our company continuously improves the quality management system. At the same time, through strict quality requirements and management, we practically adopt thorough quality management for all stages from raw materials to intermediate products to final products.
Our company improves production efficiency by introducing cutting-edge production equipment, and implements the strictest test to ensure safety and high quality through automatic computerization of the manufacturing process.
People's pursuit of health and beauty is constant, and as times change,
people have a new understanding and pursuit of health and beauty. Our goal
is to capture these new needs and contribute to a healthy life for everyone.
With enthusiasm, our staff continues to refine their technology day by day, in order to contribute to the health of all mankind.
Moreover, as the backbone of non-prescription drugs and generic drugs, our company will be constantly expanding overseas market
(mainly to southeast Asia) while developing the domestic market.
Thank you for your support all the time, and thank you for your understanding and care in the future.
|Company Name||Kokando Pharmaceutical Co., Ltd.|
|Established Date||February 1st, 1980|
|Locations||Head Office 2-8-27, Nagasuhondori, Amagasaki, Hyogo, Japan 660-0803
R&D Site 2-8-27, Nagasuhondori, Amagasaki, Hyogo, Japan 660-0803
Tokyo Office 1-7-1 Yurakucho, Chiyoda-ku, Tokyo, Japan 100-0006
Amagasaki plant 2-8-27, Nagasuhondori, Amagasaki, Hyogo, Japan 660-0803
Sanda plant 21-1 Techno-park, Sanda, Hyogo, Japan 669-1339
|Chairman CEO||KUNIO FUJIWARA|
|Capita l||250 Million Yen|
|Sales Proceeds||Sales 6427 Million Yen (for the year ended in June 2019)|
|Ordinary||794 Million Yen (for the year ended in June 2019)|
|Business Outline||Manufacturing and Sales of Medicines|
|Number of Employees||223 (as of June 30, 2019)|
|Affiliated Companies||Kokando Medicine Co., Ltd.
Head office 1-1-1 Yurakucyo,Chiyoda-Ku,Tokyo,Japan 100-0006
Daiichi Kokando Co., Ltd.
KUNIHIRO Co., Ltd.
|1981||"REISHI", as health food containing activated|
|1982||Manufacturing site in Amagasaki completed|
|1983||Manufacturing and marketing of pharmaceutical drugs started|
|1985||Tokyo Office opened|
|1986||"SENNA Tablets" launched|
|1989||"NEO CALCIUM Tablets" launched|
|1991||"BEAULUCK", for constipation, launched|
|1992||"NATURAL VITAMIN E" and "VITAMIN C Tablets" launched|
|1993||The second manufacturing site in Amagasaki relocated (merged later)|
|1994||"VITAMIN BB" launched|
|1996||"KOKANDO BENPIYAKU", for constipation, and "NEO VITAMIN EX" launched|
|1997||The first manufacturing site in Amagasaki expanded and merged as Amagasaki Plant|
|1998||"VITAMIN EC-L Tablets" launched|
|2000||Nagoya Office opened
"SOUGOUKANBOUYAKU", a cold remedy, launched
|2002||"NEOVITA C Tablets" launched|
|2003||Several pharmaceutical drugs (analgesics etc.) launched
"CONDRO POWER EX Tablets", for arthralgia, and "BIENYAKU", for Rhinitis, launched
|2007||Manufacturing site in Sanda completed
"NEOVITA WHITE PLUS" launched
|2008||Head office relocated|
|2009||"NEW NEOVITAMIN EX", "VITAMIN BB PLUS" and "ADAM A Tablets", an antipyretic analgesic, launched|
|2010||"RIPOSMIN", for insomnia, launched|
|2011||"NORIMONOYOINOKUSURI", for motion sickness, launched|
|2012||"JIYOUKYOUSOUYAKU α", as health food for nourishment and tonicity, launched
Tokyo Office relocated
|2013||"FAMOTIDINE Tablets" lanched|
|2014||"LOXOPROFEN Tablets" lanched|
|2018||"NEOVITA WHITE C PLUS" lanched|
2-8-27, Nagasuhondori, Amagasaki, Hyogo, Japan 660-0803
View larger map
2-8-27, Nagasuhondori, Amagasaki, Hyogo, Japan 660-0803
21-1 Techno-park, Sanda, Hyogo, Japan 669-1339